The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor
Open accessAbstract
Adoptive immunotherapy with regulatory T cells (Tregs) is a promising treatment for allograft rejection and graft-versus-host disease (GVHD). Emerging data indicate that, compared with polyclonal Tregs, disease-relevant antigen-specific Tregs may have numerous advantages, such as a need for fewer cells and reduced risk of nonspecific immune suppression. Current methods to generate alloantigen-specific Tregs rely on expansion with allogeneic antigen-presenting cells, which requires access to donor and recipient cells and multiple MHC mismatches. The successful use of chimeric antigen receptors (CARs) for the generation of antigen-specific effector T cells suggests that a similar approach could be used to generate alloantigen-specific Tregs. Here, we have described the creation of an HLA-A2-specific CAR (A2-CAR) and its application in the generation of alloantigen-specific human Tregs. In vitro, A2-CAR-expressing Tregs maintained their expected phenotype and suppressive function before, during, and after A2-CAR-mediated stimulation. In mouse models, human A2-CAR-expressing Tregs were superior to Tregs expressing an irrelevant CAR at preventing xenogeneic GVHD caused by HLA-A2+ T cells. Together, our results demonstrate that use of CAR technology to generate potent, functional, and stable alloantigen-specific human Tregs markedly enhances their therapeutic potential in transplantation and sets the stage for using this approach for making antigen-specific Tregs for therapy of multiple diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
Long, A. H., Haso, W. M., Shern, J. F., Wanhainen, K. M., Murgai, M., Ingaramo, M., Smith, J. P., Walker, A. J., Kohler, M. E., Venkateshwara, V. R., et al. (2015) · Nature Medicine · doi:10.1038/nm.3838 · Cited by 1,815
The Basic Principles of Chimeric Antigen Receptor Design
Sadelain, M., Brentjens, R., & Rivière, I. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0548 · Cited by 1,535
In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes
Tang, Q., Henriksen, K. J., Bi, M., Finger, E. B., Szot, G., Ye, J., Masteller, E. L., McDevitt, H., Bonyhadi, M., & Bluestone, J. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040139 · Cited by 1,221
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
Di Ianni, M., Falzetti, F., Carotti, A., Terenzi, A., Castellino, F., Bonifacio, E., Del Papa, B., Zei, T., Ostini, R. I., Cecchini, D., et al. (2011) · Blood · doi:10.1182/blood-2010-10-311894 · Cited by 1,064
Brunstein, C. G., Miller, J. S., Cao, Q., McKenna, D. H., Hippen, K. L., Curtsinger, J., DeFor, T., Levine, B. L., June, C. H., Rubinstein, P., et al. (2011) · Blood · doi:10.1182/blood-2010-07-293795 · Cited by 1,045
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Bluestone, J. A., Buckner, J. H., Fitch, M., Gitelman, S. E., Gupta, S., Hellerstein, M. K., Herold, K. C., Lares, A., Lee, M. R., Li, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad4134 · Cited by 1,033
Human T Regulatory Cells Can Use the Perforin Pathway to Cause Autologous Target Cell Death
Grossman, W. J., Verbsky, J. W., Barchet, W., Colonna, M., Atkinson, J. P., & Ley, T. J. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.002 · Cited by 1,020
Levings, M. K., Sangregorio, R., & Roncarolo, M.-G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1295 · Cited by 967
Self-citationCooke, K., Kobzik, L., Martin, T., Brewer, J., Delmonte, J. J., Crawford, J., & Ferrara, J. (1996) · Blood · doi:10.1182/blood.v88.8.3230.bloodjournal8883230 · Cited by 963
Hill, G. R., Crawford, J. M., Cooke, K. R., Brinson, Y. S., Pan, L., & Ferrara, J. L. M. (1997) · Blood · doi:10.1182/blood.v90.8.3204 · Cited by 832
Tarbell, K. V., Yamazaki, S., Olson, K., Toy, P., & Steinman, R. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040180 · Cited by 738
Trzonkowski, P., Bieniaszewska, M., Juścińska, J., Dobyszuk, A., Krzystyniak, A., Marek, N., Myśliwska, J., & Hellmann, A. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.06.001 · Cited by 683
Antibody-modified T cells: CARs take the front seat for hematologic malignancies
Maus, M. V., Grupp, S. A., Porter, D. L., & June, C. H. (2014) · Blood · doi:10.1182/blood-2013-11-492231 · Cited by 616
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Rosenberg, S. A., & Dudley, M. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.03.002 · Cited by 595
Continuous requirement for the TCR in regulatory T cell function
Levine, A. G., Arvey, A., Jin, W., & Rudensky, A. Y. (2014) · Nature Immunology · doi:10.1038/ni.3004 · Cited by 521
Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes
Joffre, O., Santolaria, T., Calise, D., Saati, T. A., Hudrisier, D., Romagnoli, P., & van Meerwijk, J. P. M. (2008) · Nature Medicine · doi:10.1038/nm1688 · Cited by 515
The promise and potential pitfalls of chimeric antigen receptors
Sadelain, M., Brentjens, R., & Rivière, I. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.02.009 · Cited by 467
Marek-Trzonkowska, N., Myśliwiec, M., Dobyszuk, A., Grabowska, M., Techmańska, I., Juścińska, J., Wujtewicz, M. A., Witkowski, P., Młynarski, W., Balcerska, A., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0038 · Cited by 431
Hoffmann, P., Eder, R., Boeld, T. J., Doser, K., Piseshka, B., Andreesen, R., & Edinger, M. (2006) · Blood · doi:10.1182/blood-2006-06-027409 · Cited by 407
Adoptive cellular therapy: A race to the finish line
June, C. H., Riddell, S. R., & Schumacher, T. N. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3643 · Cited by 403
Sagoo, P., Ali, N., Garg, G., Nestle, F. O., Lechler, R. I., & Lombardi, G. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002076 · Cited by 380
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
Fransson, M., Piras, E., Burman, J., Nilsson, B., Essand, M., Lu, B., Harris, R. A., Magnusson, P. U., Brittebo, E., & Loskog, A. S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-112 · Cited by 372
Hippen, K. L., Merkel, S. C., Schirm, D. K., Sieben, C. M., Sumstad, D., Kadidlo, D. M., McKenna, D. H., Bromberg, J. S., Levine, B. L., Riley, J. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001809 · Cited by 365
Hoffmann, P., Boeld, T. J., Eder, R., Huehn, J., Floess, S., Wieczorek, G., Olek, S., Dietmaier, W., Andreesen, R., & Edinger, M. (2009) · European Journal of Immunology · doi:10.1002/eji.200838904 · Cited by 354
Tarbell, K. V., Petit, L., Zuo, X., Toy, P., Luo, X., Mqadmi, A., Yang, H., Suthanthiran, M., Mojsov, S., & Steinman, R. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061631 · Cited by 342
Frigault, M. J., Lee, J., Basil, M. C., Carpenito, C., Motohashi, S., Scholler, J., Kawalekar, O. U., Guedan, S., McGettigan, S. E., Posey, A. D., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0186 · Cited by 323
Going viral: chimeric antigen receptor T‐cell therapy for hematological malignancies
Gill, S., & June, C. H. (2015) · Immunological Reviews · doi:10.1111/imr.12243 · Cited by 320
Continuous T Cell Receptor Signals Maintain a Functional Regulatory T Cell Pool
Vahl, J. C., Drees, C., Heger, K., Heink, S., Fischer, J. C., Nedjic, J., Ohkura, N., Morikawa, H., Poeck, H., Schallenberg, S., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.012 · Cited by 318
Golshayan, D., Jiang, S., Tsang, J., Garin, M. I., Mottet, C., & Lechler, R. I. (2007) · Blood · doi:10.1182/blood-2006-05-025460 · Cited by 313
Pancreatic Lymph Node-Derived CD4+CD25+ Treg Cells
Green, E. A., Choi, Y., & Flavell, R. A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00279-0 · Cited by 310
Tsang, J. Y.-S., Tanriver, Y., Jiang, S., Xue, S.-A., Ratnasothy, K., Chen, D., Stauss, H. J., Bucy, R. P., Lombardi, G., & Lechler, R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33185 · Cited by 271
Putnam, A. L., Safinia, N., Medvec, A., Laszkowska, M., Wray, M., Mintz, M. A., Trotta, E., Szot, G. L., Liu, W., Lares, A., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12433 · Cited by 261
Masteller, E. L., Warner, M. R., Tang, Q., Tarbell, K. V., McDevitt, H., & Bluestone, J. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3053 · Cited by 260
Blat, D., Zigmond, E., Alteber, Z., Waks, T., & Eshhar, Z. (2014) · Molecular Therapy · doi:10.1038/mt.2014.41 · Cited by 246
Allan, S. E., Alstad, A. N., Merindol, N., Crellin, N. K., Amendola, M., Bacchetta, R., Naldini, L., Roncarolo, M. G., Soudeyns, H., & Levings, M. K. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300341 · Cited by 233
Self-citationNishimura, E., Sakihama, T., Setoguchi, R., Tanaka, K., & Sakaguchi, S. (2004) · International Immunology · doi:10.1093/intimm/dxh122 · Cited by 233
Bacchetta, R., Sartirana, C., Levings, M. K., Bordignon, C., Narula, S. K., & Roncarolo, M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200208)32:8<2237::aid-immu2237>3.0.co;2-2 · Cited by 232
Self-citationBour‐Jordan, H., & Bluestone, J. A. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00775.x · Cited by 223
Helios+ and Helios− Cells Coexist within the Natural FOXP3+ T Regulatory Cell Subset in Humans
Himmel, M. E., MacDonald, K. G., Garcia, R. V., Steiner, T. S., & Levings, M. K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201379 · Cited by 217
Self-citationAn obligate cell-intrinsic function for CD28 in Tregs
Zhang, R., Huynh, A., Whitcher, G., Chang, J., Maltzman, J. S., & Turka, L. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65013 · Cited by 207
Curing CNS autoimmune disease with myelin‐reactive Foxp3+ Treg
Stephens, L. A., Malpass, K. H., & Anderton, S. M. (2009) · European Journal of Immunology · doi:10.1002/eji.200839073 · Cited by 206
Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance
Kendal, A. R., Chen, Y., Regateiro, F. S., Ma, J., Adams, E., Cobbold, S. P., Hori, S., & Waldmann, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110767 · Cited by 199
Elinav, E., Waks, T., & Eshhar, Z. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.060 · Cited by 180
Elinav, E., Adam, N., Waks, T., & Eshhar, Z. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.049 · Cited by 168
Trenado, A., Sudres, M., Tang, Q., Maury, S., Charlotte, F., Grégoire, S., Bonyhadi, M. L., Klatzmann, D., Salomon, B. L., & Cohen, J. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.1266 · Cited by 151
Babcook, J. S., Leslie, K. B., Olsen, O. A., Salmon, R. A., & Schrader, J. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7843 · Cited by 132
The Role of the PI3K Signaling Pathway in CD4+ T Cell Differentiation and Function
Han, J. M., Patterson, S. J., & Levings, M. K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00245 · Cited by 126
Self-citationSpecificity of CD4+CD25+ Regulatory T Cell Function in Alloimmunity
Sánchez‐Fueyo, A., Sandner, S. E., Habicht, A., Mariat, C., Kenny, J. J., Degauque, N., Zheng, X. X., Strom, T. B., Turka, L. A., & Sayegh, M. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.329 · Cited by 119
Discarded Human Thymus Is a Novel Source of Stable and Long-Lived Therapeutic Regulatory T Cells
Dijke, I. E., Hoeppli, R. E., Ellis, T., Pearcey, J., Huang, Q., McMurchy, A. N., Boer, K., Peeters, A. M. A., Aubert, G., Larsen, I., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13456 · Cited by 101
Self-citationAdoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation
Brunstein, C. G., Blazar, B. R., Miller, J. S., Cao, Q., Hippen, K. L., McKenna, D. H., Curtsinger, J., McGlave, P. B., & Wagner, J. E. (2013) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2013.06.004 · Cited by 96
Verginis, P., McLaughlin, K. A., Wucherpfennig, K. W., von Boehmer, H., & Apostolou, I. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800149105 · Cited by 85
Regulatory T Cells Require TCR Signaling for Their Suppressive Function
Schmidt, A. M., Lu, W., Sindhava, V. J., Huang, Y., Burkhardt, J. K., Yang, E., Riese, M. J., Maltzman, J. S., Jordan, M. S., & Kambayashi, T. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402384 · Cited by 69
Hombach, A. A., Kofler, D. M., Rappl, G., & Abken, H. (2009) · Gene Therapy · doi:10.1038/gt.2009.75 · Cited by 69
Ye, Q., Loisiou, M., Levine, B. L., Suhoski, M. M., Riley, J. L., June, C. H., Coukos, G., & Powell, D. J. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-131 · Cited by 68
Signals and pathways controlling regulatory T cells
Huynh, A., Zhang, R., & Turka, L. A. (2014) · Immunological Reviews · doi:10.1111/imr.12148 · Cited by 66
Role of HLA in Hematopoietic Stem Cell Transplantation
Park, M., & Seo, J. J. (2012) · Bone Marrow Research · doi:10.1155/2012/680841 · Cited by 52
Gu, X., Jia, X., Feng, J., Shen, B., Huang, Y., Geng, S., Sun, Y., Wang, Y., Li, Y., & Long, M. (2009) · Annals of Biomedical Engineering · doi:10.1007/s10439-009-9810-2 · Cited by 38
Albrecht, H., DeNardo, G. L., & DeNardo, S. J. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.12.012 · Cited by 35
Epigenetic analysis of regulatory T cells using multiplex bisulfite sequencing
Rainbow, D. B., Yang, X., Burren, O., Pekalski, M. L., Smyth, D. J., Klarqvist, M. D. R., Penkett, C. J., Brugger, K., Martin, H., Todd, J. A., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201545646 · Cited by 26
Research works printed but not linked: 3
- 10.1034/j.1399-0039.2000.550108.x · doi:10.1034/j.1399-0039.2000.550108.x
- 10.1111/j.1399-0039.1994.tb02363.x · doi:10.1111/j.1399-0039.1994.tb02363.x
- 10.1038/nm0103-4 · doi:10.1038/nm0103-4
Cited by
Regulatory T Cells and Human Disease
Sakaguchi, S., Mikami, N., Wing, J. B., Tanaka, A., Ichiyama, K., & Ohkura, N. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041717 · Cited by 1,120
Treg cell-based therapies: challenges and perspectives
Raffin, C., Vo, L. T., & Bluestone, J. A. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0232-6 · Cited by 720
Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses
Cho, J. H., Collins, J. J., & Wong, W. W. (2018) · Cell · doi:10.1016/j.cell.2018.03.038 · Cited by 682
CAR immune cells: design principles, resistance and the next generation
Labanieh, L., & Mackall, C. L. (2023) · Nature · doi:10.1038/s41586-023-05707-3 · Cited by 658
Kasperkiewicz, M., Ellebrecht, C. T., Takahashi, H., Yamagami, J., Zillikens, D., Payne, A. S., & Amagai, M. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.26 · Cited by 523
Metadata
- Authors
- MacDonald, K. G., Hoeppli, R. E., Huang, Q., Gillies, J., Luciani, D. S., Orban, P. C., Broady, R., & Levings, M. K.
- Venue
- Journal of Clinical Investigation
- Published
- 2016-03-21
- Volume
- 126
- Issue
- 4
- Pages
- 1413-1424
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2303852857
- Cited by
- 494
- References
- 61
- FWCI
- 24.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.